Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-21 4:57 pm Purchase | 2025-09-30 | 13G | ROCKET COMPANIES, INC. RKT | Slate Path Capital LP | 19,358,000 2.000% | 19,358,000 (New Position) | Filing History |
| 2025-08-14 4:15 pm Purchase | 2025-06-30 | 13G | TVARDI THERAPEUTICS INC PA TVRD | Slate Path Capital LP | 704,118 7.500% | 704,118 (New Position) | Filing History |
| 2025-02-14 5:00 pm Sale | 2024-12-31 | 13G | CUE BIOPHARMA INC CUE | Slate Path Capital LP | 918,836 1.400% | -1,483,619 (-61.75%) | Filing History |
| 2024-12-06 4:05 pm Sale | 2024-11-30 | 13G | CYCLERION THERAPEUTICS INC CYCN | Slate Path Capital LP | 0 0.000% | -357,880 (Position Closed) | Filing History |
| 2024-01-22 3:44 pm Unchanged | 2023-12-31 | 13G | CYCLERION THERAPEUTICS INC CYCN | Slate Path Capital LP | 357,880 14.600% | 0 (Unchanged) | Filing History |
| 2023-02-14 09:30 am Unchanged | 2022-12-31 | 13G | CUE BIOPHARMA INC CUE | Slate Path Capital LP | 2,402,455 5.600% | 0 (Unchanged) | Filing History |
| 2023-02-14 09:30 am Sale | 2022-12-31 | 13G | STITCH FIX INC SFIX | Slate Path Capital LP | 0 0.000% | -4,282,056 (Position Closed) | Filing History |
| 2023-01-13 4:30 pm Unchanged | 2022-11-01 | 13G | CYCLERION THERAPEUTICS INC CYCN | Slate Path Capital LP | 357,880 16.500% | 0 (Unchanged) | Filing History |
| 2022-11-18 4:04 pm Purchase | 2022-11-16 | 13G | CUE BIOPHARMA INC CUE | Slate Path Capital LP | 2,402,455 5.600% | 2,402,455 (New Position) | Filing History |
| 2022-10-21 5:13 pm Unchanged | 2022-10-21 | 13D | CYCLERION THERAPEUTICS INC CYCN | Slate Path Capital LP | 357,880 16.500% | 0 (Unchanged) | Filing History |
| 2022-02-14 1:15 pm Purchase | 2021-12-31 | 13G | ZIMMER ENERGY TRANSITION ACQUI ZT | Slate Path Capital LP | 2,000,000 5.800% | 2,000,000 (New Position) | Filing History |
| 2022-02-11 4:44 pm Sale | 2021-12-31 | 13G | WARNER MUSIC GROUP CORP WMG | Slate Path Capital LP | 3,134,779 2.550% | -1,355,221 (-30.18%) | Filing History |
| 2022-02-11 4:43 pm Sale | 2021-12-31 | 13G | HIPPO HOLDINGS INC HIPO | Slate Path Capital LP | 14,000 0.060% | -56,000 (-80.00%) | Filing History |
| 2022-02-11 4:41 pm Purchase | 2021-12-31 | 13G | CYCLERION THERAPEUTICS INC CYCN | Slate Path Capital LP | 357,880 16.490% | 48,077 (+15.52%) | Filing History |
| 2022-02-11 4:40 pm Purchase | 2021-12-31 | 13G | STITCH FIX INC SFIX | Slate Path Capital LP | 4,282,056 5.140% | 4,282,056 (New Position) | Filing History |
| 2022-02-11 4:39 pm Purchase | 2020-12-31 | 13G | 5:01 ACQUISITION CORP FVAM | Slate Path Capital LP | 500,000 5.800% | 500,000 (New Position) | Filing History |